Lamivudine News
Lamivudine currently has 2 news articles, with 20 predicted indications.
This page combines the AI-predicted indications for Lamivudine with the latest health news. Indications highlighted in orange have recent news coverage.
Drug Information
- Original indication: Combivir is indicated in antiretroviral combination therapy for the treatment of Human Immunodeficiency Virus (HIV) infection.
- Evidence level: L5
- Predicted indications (20):
- HIV infectious disease (100.0%)
- feline acquired immunodeficiency syndrome (99.9%)
- simian immunodeficiency virus infection (99.9%)
- neurodevelopmental disorder with ataxic gait, absent speech, and decreased cortical white matter (99.9%)
- obsolete familial combined hyperlipidemia (99.6%)
- chronic hepatitis C virus infection (99.1%)
- hepatitis B virus infection (97.8%)
- chronic hepatitis B virus infection (97.1%)
- hepatitis C virus infection (97.0%)
- hepatoportal sclerosis (96.3%)
- idiopathic copper-associated cirrhosis (96.3%)
- early-onset familial noncirrhotic portal hypertension (96.3%)
- hepatopulmonary syndrome (96.3%)
- primitive portal vein thrombosis (96.3%)
- hepatitis E virus infection (95.9%)
- AIDS (95.8%)
- hepatitis, viral, animal (95.8%)
- hepatitis A virus infection (95.7%)
- Omsk hemorrhagic fever (95.7%)
- Kyasanur forest disease (95.5%)
Related News (2)
Controversial vaccine trial touted by RFK Jr gets go-ahead in Guinea-Bissau - The Guardian
2026-10-09 hepatitis
Source: The Guardian
Meteo estremo, cibo contaminato, ricoveri lunghi. A Roma è boom di Epatite A: perché c’è da preoccuparsi
2026-10-08 epatite
Source: RomaToday
Disclaimer: The news on this page is collected automatically and is for research reference only; it does not constitute medical advice.